These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30090230)
1. Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding. Sigurdardottir AG; Winter A; Sobkowicz A; Fragai M; Chirgadze D; Ascher DB; Blundell TL; Gherardi E Chem Sci; 2015 Nov; 6(11):6147-6157. PubMed ID: 30090230 [TBL] [Abstract][Full Text] [Related]
3. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830 [TBL] [Abstract][Full Text] [Related]
4. Molecular characteristics of HGF-SF and its role in cell motility and invasion. Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W EXS; 1993; 65():311-28. PubMed ID: 8380739 [TBL] [Abstract][Full Text] [Related]
5. Developing Antagonists for the Met-HGF/SF Protein-Protein Interaction Using a Fragment-Based Approach. Winter A; Sigurdardottir AG; DiCara D; Valenti G; Blundell TL; Gherardi E Mol Cancer Ther; 2016 Jan; 15(1):3-14. PubMed ID: 26712116 [TBL] [Abstract][Full Text] [Related]
6. Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa. Pediaditakis P; Monga SP; Mars WM; Michalopoulos GK J Biol Chem; 2002 Apr; 277(16):14109-15. PubMed ID: 11832492 [TBL] [Abstract][Full Text] [Related]
7. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992 [TBL] [Abstract][Full Text] [Related]
8. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Hartmann G; Prospero T; Brinkmann V; Ozcelik C; Winter G; Hepple J; Batley S; Bladt F; Sachs M; Birchmeier C; Birchmeier W; Gherardi E Curr Biol; 1998 Jan; 8(3):125-34. PubMed ID: 9443912 [TBL] [Abstract][Full Text] [Related]
9. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. Weidner KM; Sachs M; Birchmeier W J Cell Biol; 1993 Apr; 121(1):145-54. PubMed ID: 8384622 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution. Ultsch M; Lokker NA; Godowski PJ; de Vos AM Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840 [TBL] [Abstract][Full Text] [Related]
11. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1. Niemann HH Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275 [TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Chirgadze DY; Hepple JP; Zhou H; Byrd RA; Blundell TL; Gherardi E Nat Struct Biol; 1999 Jan; 6(1):72-9. PubMed ID: 9886295 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Recio JA; Merlino G Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907 [TBL] [Abstract][Full Text] [Related]
14. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476 [TBL] [Abstract][Full Text] [Related]
15. Engineering the NK1 fragment of hepatocyte growth factor/scatter factor as a MET receptor antagonist. Youles M; Holmes O; Petoukhov MV; Nessen MA; Stivala S; Svergun DI; Gherardi E J Mol Biol; 2008 Mar; 377(3):616-22. PubMed ID: 18291418 [TBL] [Abstract][Full Text] [Related]
16. Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain. DiCara DM; Chirgadze DY; Pope AR; Karatt-Vellatt A; Winter A; Slavny P; van den Heuvel J; Parthiban K; Holland J; Packman LC; Mavria G; Hoffmann J; Birchmeier W; Gherardi E; McCafferty J Sci Rep; 2017 Aug; 7(1):9000. PubMed ID: 28827556 [TBL] [Abstract][Full Text] [Related]
17. Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Otsuka T; Jakubczak J; Vieira W; Bottaro DP; Breckenridge D; Larochelle WJ; Merlino G Mol Cell Biol; 2000 Mar; 20(6):2055-65. PubMed ID: 10688652 [TBL] [Abstract][Full Text] [Related]